Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JAC/49.1.155PMID 11751780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Necessity of a loading dose when using vancomycin in critically ill patients.

  2001cited by this paper
• Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study

  2001cited by this paper
• Influence of pharmacokinetic and pharmacodynamic principles on antibiotic selection

  2001cited by this paper
• Pharmacodynamics of Glycopeptides in the Mouse Peritonitis Model of Streptococcus pneumoniae orStaphylococcus aureus Infection

  2000cited by this paper
• Bactericidal Activity of Vancomycin in Cerebrospinal Fluid

  1999cited by this paper
• Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

  1998cited by this paper
• Mississippi mud in the 1990s

  1998cited by this paper
• Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model

  1997cited by this paper
• A closer look at vancomycin, teicoplanin, and antimicrobial resistance.

  1997cited by this paper
• Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.

  1996cited by this paper
• Vancomycin administration and monitoring reappraisal.

  1995cited by this paper
• Outpatient parenteral antibiotic therapy.

  1995cited by this paper
• Once daily antibiotic regimen in paediatric oncology.

  1994cited by this paper
• Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.

  1994cited by this paper
• SELECTING THE ANTIBIOTIC

  1993cited by this paper
• Outpatient treatment of febrile episodes in low‐risk neutropenic patients with cancer

  1993cited by this paper
• Once versus thrice daily gentamicin in patients with serious infections.

  1993cited by this paper
• The post-antibiotic effect.

  1993cited by this paper
• Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic.

  1993cited by this paper
• Necessity of a loading dose when using vancomycin in critically ill patients.

  1992cited by this paper
• Red man syndrome: incidence, etiology, and prophylaxis.

  1991cited by this paper
• In vivo postantibiotic effect in a thigh infection in neutropenic mice.

  1988cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

  1981cited by this paper
• Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.

  1980cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Vancomycin in severe staphylococcal infections.

  1961cited by this paper

• Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes.

  2026cites this paper
• Evidence of the label ototoxicity in medicines marketed in Denmark

  2025cites this paper
• Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer’s Disease

  2025cites this paper
• Parenteral medication use in hospital at home: Challenges and opportunities

  2024cites this paper
• Frequency and factors associated with infusion-related local complications of vancomycin on peripheral venous catheters.

  2023cites this paper
• The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database

  2022cites this paper
• A study to explore the appropriateness of dosing regimen of vancomycin in critically ill patients in a tertiary care unit of India.

  2022cites this paper
• 9 Vancomycin-Induced Nephrotoxicity

  2020cites this paper
• Combination of vancomycin and aminoglycosides is more nephrotoxic than individual agents alone

  2018cites this paper
• A HISTOLOGICAL RESEARCH TO ASSESS THE TOBRAMYCIN DOSE: MANAGING TOBRAMYCIN EFFECT THROUGH ANTIBIOTIC INSTEAD OF MULTIPLE INJECTIONS

  2018cites this paper
• ASHP Therapeutic Position Statements 685 Therapeutic Monitoring of Vancomycin in Adult Patients : A Consensus Review of the American Society of HealthSystem Pharmacists

  2018cites this paper
• Outpatient Intravenous Antibiotic Therapy: Reduces economic burden of patients

  2018cites this paper
• Vancomycin Administration Through a Novel Midline Catheter: Summary of a 5-Year, 1086-Patient Experience in an Urban Community Hospital

  2017cites this paper
• Top Guns: The “Maverick” and “Goose” of Empiric Therapy

  2016cites this paper
• Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin‐Tazobactam or Cefepime: A Retrospective Cohort Study

  2016cites this paper
• Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis.

  2015cites this paper
• Innovative approaches to optimizing the delivery of vancomycin in individual patients.

  2014cites this paper
• Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials.

  2014cites this paper
• Evaluation of a Once-Daily Vancomycin Regimen in an Outpatient Leukemia/Bone Marrow Transplant Clinic (OD-VANCO Study).

  2014cites this paper
• Milligrams per Liter Maintain Troughs between 15 and 20 Associated with Dosing Schedules That Vancomycin-Induced Nephrotoxicity Systematic Review and Meta-Analysis of

  2013cites this paper
• Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats

  2013cites this paper
• Vancomycin and nephrotoxicity: Just another myth?

  2013cites this paper
• Glycopeptide Antibiotics

  2012cites this paper
• Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review

  2012cites this paper
• Initial dose of vancomycin based on body weight and creatinine clearance to minimize inadequate trough levels in Japanese adults

  2012cites this paper
• Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

  2012cites this paper
• Agents with Primary Activity Against Gram-Positive Bacteria

  2011cites this paper
• Evaluation of Once-Daily Vancomycin against Methicillin-Resistant Staphylococcus aureus in a Hollow-Fiber Infection Model

  2011cites this paper
• Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

  2011cites this paper
• Intravascular Thrombophlebitis Related to the Peripheral Infusion of Amiodarone and Vancomycin

  2011influential citation
• Vestibular and Auditory Ototoxicity

  2010cites this paper
• The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid

  2010cites this paper
• Intravenous Administration Issues: A Comparison of Intravenous Insertions and Complications in Vancomycin Versus Other Antibiotics

  2010cites this paper
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

  2009cites this paper
• Vancomycin administration: mistakes made by nursing staff.

  2008cites this paper
• Cost-ineffectiveness of serum vancomycin levels

  2007cites this paper
• Miscellaneous antibacterial drugs

  2007cites this paper
• Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections

  2007cites this paper
• Not for Sale or Commercial Distribution

  2007cites this paper
• HISTOLOGICAL STUDY ON THE EFFECT OF TOBRAMYCIN DOSAGE REGIMENS ON RENAL PROXIMAL TUBULAR CELLS IN THE RATS

  2007cites this paper
• Dalbavancin: A Novel Lipoglycopeptide Antibacterial

  2006cites this paper
• Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.

  2006cites this paper
• Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

  2006cites this paper
• Safety and efficacy of glycopeptide antibiotics.

  2005cites this paper
• Medullary plasma pharmacokinetics of vancomycin after intravenous and intraosseous perfusion of the proximal phalanx in horses.

  2005cites this paper
• Administrar vancomicina de forma segura

  2005cites this paper
• Antibiotic accumulation and efflux in eukaryotic cells : a journey at the frontier of pharmacokinetics and pharmacodynamics/

  2005cites this paper
• High versus standard dose vancomycin for osteomyelitis.

  2004cites this paper
• Midline Catheters: The Middle Ground of Intravenous Therapy Administration

  2004cites this paper
• Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy.

  2004cites this paper
• Giving vancomycin safely.

  2004cites this paper
• Large Vancomycin Overdose in Two Premature Infants with Minimal Toxicity

  2004cites this paper
• Large vancomycin overdose in two premature infants with minimal toxicity.

  2004cites this paper
• Direct medical costs associated with using vancomycin in methicillin-resistant Staphylococcus aureus infections: an economic model

  2004cites this paper
• Vancomycin—Digging Bigger Troughs?

  2003cites this paper
• Vancomycin: New Perspectives on an Old Drug

  2003cites this paper
• Vancomycin: Continuously Used, Intermittently Debated

  2003cites this paper